ADRENALINE

1|Page
CREATED BY : JIGAR PRAJAPATI(NMMC)(LG HOSPITAL)

PREFACE
 THESE QUESTIONS OF SURGERY WERE ASKED IN GUJRAT UNIVERSITY
EXAMINATION FROM YEAR 2006-2022

 THE QUESTIONS ARE ARRANGED BY THEIR TOPICS AND SECTIONS.

 SIGN(*) INDICATES THAT QUESTIONS WERE ASKED AS 6 MARKS

QUESTIONS.

 YEAR – I PATTERN SHOWS EXAMINATION OF MAJOR BATCH

 YEAR -II PATTERN SHOWS EXAMINATION OF MINOR BATCH.

THANK YOU
BY,

JIGAR PRAJAPATI

MO : 8238520773

2|Page
SURGERY PAPER I

3|Page
 GENERAL SURGERY
KELOID(2016-II)

FACTORS AFFECTING WOUND HEALING(2012_II*)

VARICOSE ULCER(2009-I*,2018-II)

RODENT ULCER(2012-I)

CAUSES OF NON HEALING ULCER(2019-I)

AIDS(2006-II)

CARBUNCLE(2006-II)

NECROTIZING FASCITIS(2009-II)

D/D OF BRILLANTLY TRANSILLUMINANT SWELLING(2011-II*)

CARDIAC ARREST(2013-II,2009-I)

SIRS(2019-II)

HAEMOSTASIS(2015-I*)

FAST(2017-II)

KISS CANCER(2010-II)

BEURGER’S DISEASE(2016-I,2006-II*,2009-II*,2022-II)

Ix FOR PERIPHERAL ARTERIAL DISEASE(2017-I*)

DIFFERENTIATING FEATURES OF VARIOUS CAUSES OF CLAUDICATION(2015-II*)

DRY GANGRENE(2013-I*,2011-II)

THORACIC OUTLET OBSTUCTION(2013-I*,2006_I*)

GAS GANGRENE(2006-I*)

INTERMITTENT CLAUDICATION(2009-II)

ACUTE ARTERIAL OCCLUSION OF LOWER LIMB(2007-II*,2008-I)

4|Page
DIABETEC FOOT(2021-II*)

DEEP VEIN THROMBOSIS(2019-II*,2018-II*,2009-II,2008-II,2019-I,2021-II)

HAEMANGIOMA(2013-II*)

VARICOSE VEIN(2006-I,2015-I)

COMPLICATIONS OF VARICOSE VEINS(2016-I)

TARDY ULNAR PALSY(2018-I*)

RAYNAUD’S PHENOMENON(2019-II*,2022-II)

AV FISTULA(2022-II)

BASAL CELL CARCINOMA(2017-II,2009-II*,2021-II)

MALIGNANT MELANOMA OF SKIN(2015-I*)

SQUAMOUS CELL CARCINOMA(2022-I*,2022-II)

RODENT ULCER(2012-I)

Mx OF DIABETIC FOOT(2008-I*)

KIDNEY TRANSPLANTATION PROGRAMME(2015-I*)

UNIVERSAL PRECAUTION(2006-I*)

PEDICAL GRAFTS(2006-I)

SKIN GRAFTS AND ITS TYPES(2006-II)

HYPOCALCAEMIA(2008-II)

PRINCIPLES OF DAMAGE CONTROL SURGERY(2021-II)

FACIOMAXILLARY DISEASE
ADAMANTINOMA(2007-I,2009-II*,2016-I)

EPULIS(2006-II*,2009-I,2015-II)

ODONTOME(2018-I)

5|Page
DENTIGEROUS CYST(2013-I)

MALIGNANT LESION OF OROPHARYNX(2019-I)

ORAL CAVITY
MAXILLARY TUMOUR(2014-I*)

D/D OFSUBMANDIBULAR SWELLING(2007-II)

TONGUE TIE(2019-II)

TOUNGE ULCER D/D(2020-I)

CARCINOMA TONGUE(2021-I)

MANAGEMENT OF CLEFT LIP(2022-II*)

SALIVARY GLAND
PLEOMORPHIC ADENOMA(2009-II,2022-I*)

WARTHIN TUMOUR(2012-I)

NECK
CYSTIC HYGROMA(2009-II,2018-II)

COLD ABSCESS IN NECK(2012-I)

THYROID
TREATMENT OF THYROTOXICOSIS(2007-II*)

PRIMARY THYROTOXICOSIS(2009-II*)

6|Page
 THYROGLOSSAL CYST(2022-I,2018-I*)

TSH(2018-I)

RETROSTERNAL GOITRE(2007-I,2018-II)

THYROID FUNCTION TEST(2008-I,2017-II)

SOLITARY THYROID NODULE(2008-II,2009-II,2010-II*,2011- II*

,2016-II*,2016-I)

HASHIMOTO THYROIDITIS(2015-II)

PAPILLARY CARCINOMA OF THYROID(2014-II*)

HYPERTHYROIDISM (2012-II*,2013-I,2021-I)

THYROGLOSSAL FISTULA(2022-II)

NEUROLOGICAL COMPLICATIONS OF THYROID SURGERY(2019-I)

EYE SIGNS OF GRAVES DISEASE AND ITS PATHOGENESIS(2019-II*)

PARATHYROIDS AND ADRENALS

PARATHYROID ADENOMA(2018-II)

PHEOCHROMOCYTOMA(2007-II*,2015-I,)

MEN (2008-I)

ADDISON DISEASE DIAGNOSIS AND MANGEMENT(2019-I*)

BREAST
LYMPHATIC DRAINAGE OF BREAST(2019-II*,2012-II,2013-II)

LYMPHATIC DRAINAGE OF BREAST AND STAGING OF CARCINOMA(2018-II*)

PAGET DISEASE OF BREAST(2008-I,2016-II)

7|Page
CYSTOSARCOMA PHYLLODES(2009-I,2022-I,2016-I,2018-II)

CLINICAL FEATURES AND Rx OF CYSTOSARCOMA PHYLLODES(2012-I,2013-

I,2017-II)

ADVANCED BREAST CANCER(2009-II,2014-I,2014-II*)

CLINICAL Mx OF ADVANCED BREAST CANCER(2013-I)

TREATMENT OF STAGE II CARCINOMA BREAST(2007-I*,2008-II*)

STAGING OF CARCINOMA BREAST(2021-I)

ENDOCRINE TREATMENT OF BREAST CARCINOMA(2007-I*)

TOILET MASTECTOMY(2010-II)

BENIGN BREAST DISEASE(2013-I,2007-II*,2017-I)

FIBROADENOMA OF BREAST(2011-II,2016-II)

TRIPLE ASSESMENT OF BREAST LUMP(2008-I*,2015-I,2020-II, 2021-II*)

MAMMOGRAPHY(2006-I,2007-II,2012-I)

PERITONEUM
SUBPHRENIC ABSCESS(2007-I)

MESENTRIC CYST(2006-I,2018-II,2020-II)

PERITONITIS ,CLINICAL FEATURES AND Mx(2008-I*)

INTRA ABDOMINAL ABSCESS(2009-II*)

ABDOMINAL TUBERCULOSIS
ABDOMINAL TB(2016-I*)

Mx OF ILEOCAECAL TB(2022-I)

8|Page
 LIVER
AMOBIC LIVER ABSCESS(2008-II,2006-I,2009-II,2014-II,2017-I) Mx OF
AMOBIC LIVER ABSCESS(2011-II)

OESOPHAHEAL VARICES(2016-I*,2015-II*)

HYDATID CYST OF LIVER ,CLINICAL FEATURES AND Mx(2007-II*,2006-II)

DIAGNOSIS AND Mx OF HYDATID CYST OF LIVER(2022-I)

Mx OF HYDATID CYST OF LIVER(2016-I)

SITES OF PORTO SYSTEMIC ANASTOMOSIS(2007-I,2012-I)

GALL BLADDER
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY(ERCP)(2012-
I,2013-I,2014-II,2017-I)

COURVOISERS LAW(2017-II,2019-II)

ETIOPATHO ,C/F AND Mx OF ACUTE CHOLECYSTITIS(2007-I,2020-II*)

OBSTRUCTIVE JAUNDICE(2021-I)

INVESTIGATIONS FOR OBSTRUCTIVE JAUNDICE(2014-I)

USES OF T-TUBE IN CHOLEDOCHOLITHOTOMY(2017-II*)

COMPLICATIONS OF GALL STONES(2017-II*,2021-I*,2007-II)

LAP CHOLECYSTECTOMY(2012-I*,2016-I)

COMPLICATIONS OF CALCULUS CHOLECYSTITIS(2016-II*)

MANAGEMENT OF STONED IN CBD(2022-II)

CLINICAL FEATURES OF CHOLEODECAL CYST(2021-II)

9|Page
 SPLEEN
HYPERSPLENISM(2006-I)

CLINICAL PRESENTATION OF SPLENIC RUPTURE(2007-I)

COMPLICATIONS OF SPLENECTOMY(2012-I,2021-II)

INDICATIONS AND COMPLICATIONS OF SPLENECTOMY(2022-I)

INDICATIONS OF SPLENECTOMY(2007-II)

PANCREAS
MRCP(2018-I,2013-II)

CAUSES OF ACUTE PANCREATITIS(2017-I*,2015-II)

Mx OF ACUTE PANCREATITIS(2014-II*,2021-II*)

COMPLICATIONS OF ACUTE PANCREATITIS(2010-II,2013-II)

ACUTE PANCREATITIS(2012-II)

C/F AND DIAGNOSIS OF ACUTE PANCREATITIS(2021-I)

ETIOPATHOGENESIS OF ACUTE PANCREATITIS(2019-I*)

RANSON SCORE FOR ACUTE PANCREATITIS(2007-I)

GASTRINOMA(2008-I*)

PSEUDOCYST OF PANCREAS(2015-I,2022-I)

Mx OF PSEUDO PANCREATIC CYST(2014-I)

SURGICAL ANATOMY OF GALLBLADDER,ANATOMY VARIATIONS AND Mx OF

ACUTE CHOLECYSTITIS(2008-II*)

DIFFERENTIAL DIAGNOSIS OF MASS ABDOMEN

MASS IN RIGHT ILLIAC FOSSA(2011-II*,2012-II*)

10 | P a g e
ABDOMINAL WALL AND UMBILICUS
EXOMPHALUS(2010-II*)

VITELO INTESTINAL DUCT(2006-I,2015-II)

COMPLICATIONS OF OMPHALITIS(2015-II)

HERNIA
EPIGASTRIC HERNIA(2012-I,2020-II)

SURGICAL ANATOMY OF INGUINAL HERNIA AND Mx OF STRANGULATED

INGUINAL HERNIA(2012-II*)

OBTURATOR HERNIA(2013-I*)

DIAPHRAGMATIC HERNIA(2010-II*,2006-I)

BILATERAL HERNIA(2020-II*)

SPIGELIAN HERNIA(2006-II,2019-II)

DEEP RING OCCLUSION TEST(2018-I)

HERNIOPLASTY2017-II)

RICHTER HERNIA(2009-I)

OESOPHAGUS
ACHALASIA CARDIA(2009-I*,2011-II,2012-II,2014-I,2018-II)

DIAGNOSIS AND Mx OF ACHALASIA CARDIA(2022-I*)

11 | P a g e
TRACHEO-OESOPHAGEAL FISTULA(2013-I,2017-I,2018-II,2014-I*)

OESOPHGEAL ATRESIA AND TREACHEO-OESOPHAGEAL FISTULA(2007-II)

CARCINOMA OESOPHAGUS(2008-II*)

CAUSES AND INVESTIGATION OF DYSPHAGIA(2017-I*)

HIATUS HERNIA(2013-I*)

BARRETTS OESOPHAGUS(2013-I)

STRICTURES OF OESOPHAGUS(2013-I)

STOMACH
LINTIS PLASTICA(2010-II*)

INVESTIGATION,ETIOLOGY AND Rx OF CARCINOMA STOMACH(2018-II*,2017-

II,2016-II*)

INVESTIGATION AND Mx OF PERFORTED DUODENAL ULCER(2018-II*)

Mx 0F ACUTE PEPTIC PERFORATION OF DUODENUM(2015-II,2022-II*)

COMPLICATION OF PEPTIC ULCER(2020-II*)

CAUSES OF HAEMATEMESIS AND Mx(2017-I*,2013-II*)

HAEMATEMESIS(2013-I,2011-II)

GASTO INTESTINAL STROMAL TUMOUR(2017-I,2013-II*,2021-II*)

GASTRIC OUTLET OPERATION(2016-I*)

RAMSTEDTS OPERATION(2016-II,2019-I)

LYMPHATIC DRAINAGE OF STOMACH(2014-II,2013-I,2011-II,2007-I,2009-I)

CONGENITAL HYPERTROPHIC PYLORIC STENOSIS(2012-II,2012-I*,2007-I*)

Mx OF UPPER GI BLEEDING(2021-I*)

CLINICAL FEATURES AND DIAGNOSIS OF CARCINOMA STOMACH(2022-I*)

12 | P a g e
VISUAL GASTRIC PERISTALSIS(2019-II)

SMALL INTESTINE
MECKELS DIVERTICULUM(2016-II,2020-II,2022-I,2022-II*)

COMPLICATIONS OF MECKEL DIVERTICULUM(2013-I*)

C/F AND DIAGNOSIS OF SMALL BOWEL ISCHEMIA(2019-I*)

LARGE INTESTINE
DIFF B/W ULCERATIVE COLITIS AND CROHNS DISEASE(2014-II)

ULCERATUVE COLITIS(2013-II*,2007-II)

CLINICAL FEATURE AND DIAGNOSIS OF CARCINOMA COLON(2021-I*)

DIFF B/W CLINICAL FEATURES CARCINOMA RIGHT SIDED AND LEFT SIDED
COLON(2015-II)

INTESTINAL OBSTRUCTION
Mx OF SIGMOID VOLVULUS(2022-I*)

SIGMOID VOLVULUS(2007-I,2010-II,2006-I*)

RED CURRANT JELLY(2018-I)

SIGNE DE DANCE(2018-I)

INTUSSUSCEPTION(2020-II,2017-II)

CLASSIFY INTESTINAL OBSTRUCTIONS(2014-I*)

PARALYTIC ILLEUS(2013-II)

SUBACUTE INTESTINAL OBSTRUCTION(2006-II*)

13 | P a g e
 APPENDIX
ACUTE APPENDICITIS(2009-I*)

CLINICAL FEATURES AND Mx OF ACUTE APPENDICITIS(2016-II*)

OSCHNER SHERREN REGIMEN(2022-I)

McBURNEY POINT(2018-I)

APPENDICULAR LUMP AND Mx (2017-I,2015-II,2021-II*)

CARCINOID TUMOUR OF APPENDIX(2015-I*,2008-II)

VERMIFORM APPENDIX(2013-II*)

RECTUM AND ANAL CANAL

ACUTE FISSURE IN ANO(2018-I,2007-II,2008-I)

PILONIDAL SINUS(2018-II,2013-I,2011-II*)
HAEMORRHOIDS(2017-I,2013-I*,2012-I,2020-II*)

Mx OF HAEMORRHOIDS(2022-II,2009-II)

GOODSALL RULE(2017-II)

IMPERFORATE ANUS(2017-II*,2011-II,2006-I,2020-II)

RECTAL PROLAPSE AND Mx(2021-I,2019-II*,2014-I)

CLASSIFICATION OF FISTULA IN ANO AND Mx (2022-I,2019-I)

ANORECTAL MALFORMATIONS(2014-II*,2008-II*)

CARCINOMA OF RECTUM(2009-I*)

SACROCOCCYGEAL TERATOMA(2013-II,2010-II)

ISCHIORECTAL ABSCESS(2013-II)

14 | P a g e
FISTULA IN ANO(2012-II)

LOWER GI BLEEDING , CAUSES AND Mx(2012-I*)

UROLOGY
KIDNEY
MASSIVE HEMATURIA(2009-II)

RENAL CALCULUS(2018-II)

SYMPTOMS OF KIDNEY STONE(2018-I*)

NON OPERATIVE AND MINIMAL INVASIVE Rx OF RENAL STONE(2017-II*)

STAGHORN CALCULUS(2016-II)

PERCUTANEOUS (NEPHROLITHOTOMY)(2013-I)

ETHIOPATHOGENESIS OF RENAL STONES(2012-II*,2019-I*)

POLYCYSTIC KIDNEY(2013-I)

DIAGNOSIS AND Rx OF POLYCYSTIC KIDNEY(2017-II*)

HYDRONEPHROSIS(201-II*,2018-II*)

HYDRONEPHROSIS C/F AND Mx(2022-I*)

RENAL CELL CARCINOMA(2016-I*)

WILM’S TUMOUR(2007-II*,2009-II,2016-II*)

HORSESHOE KIDNEY(2012-II,2022-II*)

RENAL TB(2014-II*,2008-II*)

HEMATURIA(2013-I*,2006-II*)

RENAL TUMOUR(2013-II*,2015-II*)

Mx OF CALCULUS IN URETER(2019-I)

15 | P a g e
 URINARY BLADDER
CARCINOMA OF URINARY BLADDER(2014-I*)

STAGING OF CARCINOMA OF BLADDER(2014-II)

ETHIOPATHOGENESIS AND TREATMENT OF CARCINOMA BLADDER(2007-I*)

RUPTURE OF URINARY BLADDER(2007-II*,2020-II)

C/F AND Mx OF VESICAL CALCULUS(2022-II)

PROSTATE
LUTS(2017-II)

BENIGN PROSTATIC HYPERPLASIA(2016-I*)

Mx OF BPH(2014-II*,2020-II,2022-II*)

CLINICAL FEATURES AND Mx OF BPH (2021-I*,2013-II)

TURP AND ITS COMPLICATIONS(2021-II,2016-II)

PROSTATISM(2013-I)

URETHRA
HYPOSPADIAS(2007-II,2021-I)

RUPTURED URETHRA(2016-I*)

CAUSES OF HEMATURIA .Mx OF CASE OF URETHRAL INJURY(2013-I*)

ACUTE RETENTION OF URINE(2012-II*)

STRICTIRE URETHRA(2006-I)

16 | P a g e
 PENIS
CIRCUMSISION(2009-I)

PARAPHIMOSIS(2018-I,2013-I)

INVESTIGATION AND Mx OF CARCINOMA PENIS(2018-II*)

PREMALIGNANAT LESIONS OF CARCINOMA PENIS(2014-II,2013-I*)

PRIAPISM(2017-I)

PHIMOSIS AND ITS COMPLICATION(2017-II,2016-I,2011-II,2020-II)

SCROTUM
HYDROECELE(2022-II*)

VAGINAL HYDROECELE(2011-II*)

VARICOCELE(2006-I*)

FOURNIER’S GANGRENE OF SCROTUM(2014-I,2006-II)

TESTIS
ECTOPIC TESTIS(2018-I*)

TESTICULAR TUMOURS(2017-I*,2016-II*,2013-I*)

UNDESCENDED TESTIS(2015-I,2013-II,2021-II*)

EMBRYOLOGY OF TESTIS DESCENT .Mx OF IMPERFECT DESCENT OF

TESTIS(2013-I*)

SEMINOMA TESTIS(2008-I*,2020-II*)

TORSION OF TESTIS(2015-II*,2012-II*.2007-II,2022-I)

17 | P a g e
 NEUROSURGERY
GLASGOW COMA SCALE(2012-I*)

HYDROCEPHALUS(2021-I)

SPINIA BIFIDA(2022-I)

Mx OF SUBDURAL HAEMATOMA(2022-II)

MENINGEOCELE(2022-II)

C/F AND Mx OF MENINGO MYELOCELE(2019-I)

LUCID INTERVAL(2021-II)

THORAX
FLIAL CHEST(2017-I,2012-II,2006-I)

CAUSES AND Rx OF EMPYEMA(2017-I*)

STOVE IN CHEST(2010-II)

TRIANGLE OF SAFETY(2017-II)

IMMEDIATE LIFE THREATINING INJURY TO CHEST(2015-I*)

TENSION PNEMOTHORAX(2013-I)

DIAPHRAGMATIC HERNIA(2012-II*)

ADJUVANT THERAPY
BRACHYTHERAPY(2016-I,2016-II)

GENE THERAPY(2014-I)

18 | P a g e
 ANAESTHESIA
SPINAL ANAESTHESIA(2011-II,2006-II,2022-II)

COMPLICATIONS OF SPINAL ANAESTHESIA(2019-I)

LOCAL ANAESTHSEIA(2018-I,2017-I,2012-II,2012-I,2009-I,2020-II)

EPIDURAL ANAESTHESIA(2008-II,2016-II,2013-I,2006-I,2007-I,2007-II)

ANAESTHETIC AGENTS(2021-I,2021-II)

REGIONAL ANAESTHESIA(2021-I)

DISSOCIATIVE ANAESTHESIA(2015-II*)

PRE ANAESTHETIC MEDICATION(2014-II)

COMPLICATIONS OF GENERAL ANAESTHESIA(2010-II,2013-I)

ADVANCED IMAGING METHODS

ULTRASONOGRAPHY(2011-II)

TELE RADIOTHERAPY(2019-II)

IMAGING IN ACUTE ABDOMEN(2009-I)

INVESTIGATION IN GASTODUODENAL DISEASE(2008-I)

OPERATIVE PROCEDURES
ADVANTAGES AND LIMITATIONS OF LAPROSCOPIC SURGERY(2015-I,2007-II)

SINGLE PORT LAP SURGERY(2013-I)

NON ABSORBABLE SUTURES(2014-I)

DAY CARE SURGERY(2014-II)

19 | P a g e
TRACHEOSTOMY(2011-II)

HYPERBARIC OXYGEN THERAPY(2006-II*)

MISC
BLOOD NIPPLE DISCHARGE(2018-I*)

FREE GAS UNDER DIAPRAGM(2018-I)

CHYLE LEAK(2017-I)

PET SCAN(2016-I)

PSOAS ABSCESS(2019-II)

REFERRED PAIN(2019-II)

PATENT PROCESSUSVAGINALIS(2016-II)

EPISTAXIS(2012-II)

SENTINEL LYMPH NODE BIOPSY(2014-II)

D/D OF OBSTUCTIVE UROPATHY(2014-I)

RADIOLOGICAL STUDY OF HEPATOBILIARY SYSTEM(2015-I)

ENDOSCOPIC ASSESMENT OF SMALL INTESTINE(2015-I)

20 | P a g e
SURGERY PAPER II

21 | P a g e
 GENERAL SURGERY
WOUNDS AND WOUND HEALING
FACTORS AFFECTING WOUND HEALING (2022-II*,2020-II*,2018-II,2012-II)

COMPLICATION OF SCAR(2017-II)

WOUND HEALING (2016-I*)

CRUSH SYNDROME (2007-II,2016-I)

TYPES OF WOUND HEALING (2021-II,2016-I)

STAGES OF WOUND HEALING (2014-I)

KELOID (2007-II,2014-II)

ASEPSIS AND ANTISEPTIC IN PREVENTION OF WOUND(2009-II*)

ULCER
VAC DRESSING (2018-II)

RODENT ULCER (2016-II,2014-I,2006-I)

BED SORE / PRESSURE SORE(2012-I,2007-I)

CLINICAL VARIATIONS OF ULCER(2011-II)

TROPICAL ULCER(2006-II)

DECIBITUS ULCER2009-II*)

TUBERCULOUS ULCER(2021-I)

BIOLOGICAL DRESSING(2010-II)

MARJOLIN ULCER(2009-I,2020-II)

22 | P a g e
 SINUS AND FISTULA
HILTON METHOD OF ABSCESS DRAINAGE(2009-I)

CAUSES OF PERSISTENCE OF FISTULA(2018-I)

INFECTIOUS DISEASE
ACUTE PARONCHYIA(2022-I)

TREATMENT OF SUPERFICIAL ABSCESS(2022-II)

SYPHILIS (2017-I)

DOTS REGIME(2017-II)

TETANUS(2016-I)

MX OF TETANUS CASE(2011-II*)

GAS GANGRENE(2016-I,2014-I,2008-I,2012-I,2007-I*)

ANAL COMPLICATIONS OF HIV AIDS(2015-II*)

PRECAUTIONS IN SURGERY ON HIV PATIENT(2013-I)

BACTERIAL SYNERGISTIC GANGRENE (2015-II,2013-I*)

CARBUNCLE(2015-II,2020-II,2007-II)

SURGICAL SITE INFECTION(2014-I*)

MX OF DOG BITE (2014-I)

NOSOCOMIAL INFECTIONS IN SURGICAL WARD(2013-II,2007-I,2007-II)

MYCETOMA FOOT(2013-I,2010-II)

ACTINOMYCOSIS(2007-I)

SURGERY IN AIDS PATIENT(2009-I*)

NECROTIZING CELLULITIS(2008-II)

23 | P a g e
 SWELLINGS
LIPOMA(2020-II*,2022-II)

EPIDERMAL CYST(2011-II)

ELECTROLYTE AND NUTRITION

RESPIRATORY ALKALOSIS(2022-I)

HYPERKALEMIA(2007-I)

TOTAL PARENTERAL NUTRITION (TPN) (2014-I,2012-II,2007-I)

FEEDING JEJUNOSTOMY (2014-II,2008-II)

METABOLIC ALKALOSIS (2014-II)

ENTERAL NUTRITION(2013-II*)

HYPERCHLOREMIC ACIDOSIS(2013-I)

HYPOKALAEMIA (2012-II,2008-I,2021-I)

HYPOKALEMIA ALKALOSIS(2009-I)

HYPONATREMIA(2009-II,2008-II)

SHOCK
CLASSIFICATION OF SHOCK(2019-I*)

CAUSES OF SHOCK AND Mx(2022-I*,2022-II*)

HYPOVOLAEMIC SHOCK (2016-I,2007-II*,2008-II*)

PATHOPHYSIOLOGY OF HYPOVOLAEMIC SHOCK (2014-I*,2014-II)

MODS (2014-I)

24 | P a g e
 STAGES OF SHOCK. ENDOTOXIC SHOCK (SEPTIC SHOCK) (2013-II*,2008-
I*,2020-II*)

HIGH OUTPUT SEPTIC SHOCK(2009-II)

SIRS(2013-I,2007-I,2010-II,2021-II)

HAEMORRHAGE AND BLOOD TRANSFUSION

PREVENTION & MX OF SECONDARY HAEMORRHAGE (2017-II*)

HAEMORRHAGE (2016-I*)

TYPES OF HAEMORRHAGE (2015-II,2021-I*)

INDICATIONS OF BLOOD TRANSFUSION IN SURGERY(2017-II*)

COMPLICATIONS OF BLOOD TRANSFUSION (2016-I*,2009-II*,2014-I,2014-

II,2019-I)

BLOOD TRANSFUSION REACTION(2012-II)

MASSIVE BLOOD TRANSFUSION & ITS COMPLICATION(2016-II*)

MASSIVE BLOOD TRANSFUSION (2013-I)

HAEMOPHILIA (2015-II)

BLOOD SUBSTITUTES (2015-II)

HAEMOSTASIS IN SURGERY (2013-II)

BURNS
TYPES OF BURNS(2020-II)

Mx OF DEEP BURNS(2021-I)

CLASSIFICATION OF BURNS AND ITS Mx(2022-I*)

Mx OF 30% SUPERFICIAL AND DEEP BURNS(2022-II*)

25 | P a g e
PATHOPHYSIOLOGY & MX OF 30% BURNS(2018-II)

TYPES & QUANTITIES OF FLUID USED TO TREAT A 50 YEARS OLD FEMALE WITH
40% BURN (2017-II*)

FLUID RESUSCITATION IN BURN PATIENT(2016-I*)

MX OF 30% BURNS OVER FACE NECK CHEST & RIGHT UPPER EXTREMITY(2012-
II*)

WALLACE’S RULE OF NINE FOR BURN PATIENT(2016-II)

PARKLAND FORMULA, CALCULATE IV FLUID REQUIREDFOR 48 HOURS IN

PATIENT OF 60KG & 40% BURN (2015-II,2021-II)

MX OF 35% BURNS IN 40 YEARS OLD 50 KG WEIGHT(2014-I)

MX OF ACID INGESTION(2017-I)

TRAUMA
BLAST INJURIES (2017-I*)

TRIAGE (2016-I*,2010-II)

DISCUSS TYPES OF INJURIES WITH THEIR LOCAL & GENERAL EFFECTS(2013-I)

HAND AND FOOT

COLLAR STUD ABSCESS (2016-II,2006-I,2022-I)

ARTERIAL DISEASE
FAT EMBOLISM (2018-I,2012-II)

DIABETEC FOOT(2009-I)

LERECHIE SYNDROME(2006-I*)

CRITICAL LIMB ISCHAEMIA (2014-II)

FROSTBITE (2014-I)

26 | P a g e
THROMBOANGITIS OBLITERANS(2010-II*)

VENOUS DISEASE
CHRONIC VENOUS INSUFFICIENCY(2017-I*)

DEEP VEIN THROMBOSIS(2022-I*)

MX OF DEEP VEIN THROMBOSIS (2014-I)

MX OF VARICOSE VEINS (2014-II*,2014-I)

VARICOSE VEIN(2011-II*,2021-I*)

LYMPHATICS
LYMPHOEDEMA(2018-II,2013-II,2008-I)

PERIPHERAL NERVES
WRIST DROP (2018-I)

RADIAL NERVE PALSY / INJURY DUE TO FRACTURE OF HUMERUS(2016-I)

FOOT DROP (2018-II)

ULNAR PARADOX(2019-I)

NEOPLASM
SPREAD OF MALIGNANT TUMOUR (2013-II)

PARANEOPLASTIC SYNDROME(2009-II)

SKIN TUMOURS
HEMANGIOMA(2022-II)

MALIGNANT MELANOMA(2008-I*)

BASAL CELL CARCINOMA / RODENT ULCER (2018-II,2016-II,2007-II*,2008-II*)

27 | P a g e
PATHOLOGY OF MALIGNANT MELANOMA AND Mx(2007-I*,2014-II)

CLINICAL TYPES OF MM & MX OF MM OF SOLE OF FOOT STAGE II-b(2013-I*)

RECONSTRUCTIONS
Skin Grafting (2016-II,2019-II)

TYPES OF SKIN GRAFTING(2021-I)

SPLIT THICKNESS SKIN GRAFTING(2020-II)

PAIN
PAIN CONTROL IN BENIGN TUMOUR(2015-II*)

FACIOMAXILLARY DISEASES
CLASSIFICATION OF LIP & PALATE ABNORMALITIES(2016-I)

ORAL CAVITY
LYMPHATIC DRAINAGE OF TONGUE & SURGICAL MX OF CA TONGUE (2009-
I,2018-II*)

CA TONGUE(2016-I,2006-I)

PREMALIGNANT LESIONS OF ORAL CAVITY(2018-II,2012-II)

MACROGLOSSIA (2017-I)

RANULA (2016-I,2006-II)

LEUKOPLAKIA (2011-II,2009-I)

CLEFT LIP(2009-I)

LUDWIG ANGINA(2019-I)

28 | P a g e
 SALIVARY GLANDS
PLEOMORPHIC ADENOMA OF PAROTID GLANDS(2018-II*,2016-II*,2010-
II*,2019-II)

MIXED PAROTID TUMOUR(2011-II,2007-I*,2008-II,2020-II)

COMPLICATION OF PAROTID GLAND SURGERY (2016-I)

SURGICAL IMPORTANCE OF FACIOVENOUS PLANE OF PATEY(2015-II)

CLASSIFICATION OF SALIVARY GLAND TUMOURS (2014-I)

PAROTID ABSCESS (2012-II)

WALDEYERS RING(2006-I*)

FREY SYNDROME(2007-II)

METHOD OF IDENTIFICATION OF FACISL NERVE DURING PAROTID GLAND

SURGERY(2019-I)

NECK
BRACHIAL CYST (2018-I,2018-I,2007-I,2009-II,2008-I)

CYSTIC HYGROMA(2017-II,2007-II)

THORACIC OUTLET SYNDROME (2017-I)

CERVICAL RIB(2010-II,2008-II*)

CERVICAL LYMPHADENOPATHY(2016-I)

DIAGRAM OF TRIANGLES OF NECK. IMP SWELLINGS IN IT(2012-I*)

LYMPHATIC DRAINAGE OF NECK (2016-II)

CAROTID BODY TUMOUR (2016-I)

TUBERCULAR LYMPHADENOPATHY OF NECK(2014-I,2011-II,2022-II)

PATHOLOGY & CLINICAL FEATURES OF TB CERVICAL LYMPHADENITIS(2012-II*)

COLD ABSCESS IN NECK (2014-II*,2014-I,2019-I)

29 | P a g e
SUBHYOID BURSITIS (2011-II)

TB LYMPHADENITIS(2009-I*,2019-II*)

HODGKIN LYMPHOMA(2022-I)

COLLAR STUD ABSCESS(2022-I)

THYROID
COMPLICATIONS OF TOTAL THYROIDECTOMY (2018-I*)

THYROGLOSSAL FISTULA (2017-II)

THYROGLOSSAL CYST (2016-II,2008-II)

EXOPHTHALMOS (2016-I)

OUTLINE RX OF THYROTOXICOSIS(2016-I)

MALIGNANT NEOPLASM OF THYROID (2013-II*)

PARATHYROID
HYPOPARATHYROIDISM(2006-II)

BREAST
TRIPLE ASSESSMENT (2017-II)

CONSERVATIVE BREAST SURGERY(2006-I)

PERITONEUM
TYPES OF MESENTERIC CYST & ITS PRESENTATION (2017-I*)

LIVER
LIVER ABSCESS(2019-II)

GALL BLADDER
TRABSDUODENAL SPHINCTERECTOMY(2006-I)

30 | P a g e
 ABDOMINAL WALL AND UMBILICUS
BACTERIAL SYNERGISTIC GANGRENE (2015-II,2013-I*)

HERNIA
PREOPERATIVE PREPARATIONS FOR INGUINAL HERNIA(2018-I*)

STOMACH
CHEST COMPLICATIONS AFTER GASTRECTOMY(2018-I*)

HYPERTROPHIC PYLORIC STENOSIS(2021-II*)

INTESTINAL OBSTRUCTIONS
SIGMOID VOLVULUS CLINICAL FEATURES & MX (2012-I*)

RECTUM AND ANAL CANAL

PILONIDAL SINUS(2008-I,2019-II)

UROLOGY
KIDNEY
TREATMENT OF RENAL CALCULI(2021-II*)

HEPATO RENAL SYNDROME(2022-II)

USES OF CATHETER (2018-I)

RENAL CELL CARCINOMA CLINICAL FEATURES(2012-I)

WILMS TUMOUR(2006-I*)

PROSTATE
PROSTATIC ANTIGEN(2012-I)

PENIS
PREMALIGNANT LESIONS OF CARCINOMA PENIS (2012-I)

31 | P a g e
 SCROTUM
CONGENITAL HYDROCELE ETIOLOGY & RX(2012-I)

NEUROSURGERY
MENINGOCELE(2017-I)

GLASCOW COMA SCALE – EYE SIGNS(2017-II,2016-II,2013-II,2021-I)

ETIOPATHO, CLASSIFICATION & MX OF HYDROCEPHALUS(2016-II*)

HYDROCEPHALUS (2012-II,2022-II)

CEREBRAL CONCUSSION(2008-II)

CAUSES AND CLINICAL SIGNS OF RAISED ICP(2019-I)

EXTRADURAL HAEMATOMA (2016-I*,2022-I,2013-I,2020-II)

MIDDLE MENINGEAL ARTERY SYNDROME(2015-II*)

LUCID INTERVAL (2014-II)

SUBDURAL HEMATOMA(2014-I*,2006-I*,2021-II*)

CLINICAL FEATURES & MX(2012-II*)

SPINIA BIFIDA(2006-I)

PUPILLARY CHANGES IN HEAD INJURY(2006-II*)

THORAX
FLAIL CHEST(2018-II,2019-I*,2021-II,2022-I)

STOVE IN CHEST(2022-II)

PNEUMOTHORAX (2012-I)

HAEMOTHORAX(2020-II)

TENSION PNEUMOTHORAX(2006-II*,2009-II,2019-I)

INTERCOSTAL DRAINAGE(2021-I)

32 | P a g e
EMPYEMA THORACIS(2021-I)

ADJUVANT THERAPY
MONOCLONAL ANTIBODY(2013-I)

OPERATIVE PROCEDURES
CONTRAINDICATIONS OF LAPAROSCOPY(2018-I)

DAY CARE SURGERY (2018-II)

NON-ABSORBABLE SUTURE MATERIAL (2018-II)

PRINCIPLE OF LAPAROSCOPIC SURGERY (2013-II)

STERILIZATION BY AUTOCLAVE (2012-I*)

AUTOCLAVING (2011-II)

VASECTOMY (201-II,2009-I)

LAPROSCOPY(2006-II)

INDUCTION CHEMOTHERAPY(2009-II)

MISC
CAUSES OF GENERALISED LYMPHADENOPATHY(2018-I)

INSENSIBLE LOSS OF FLUIDS (2018-I)

ARDS (2018-II*)

PALMAR GANGLION (2017-I)

PNEUMOPERITONEUM (2017-I)

ADVANTAGE OF MINIMAL ACCESS SURGERY(2017-II)

PRINCIPLES OF INTESTINAL RESECTION & ANASTOMOSIS(2014-I*)

CPR (2014-I)

33 | P a g e
UNIVERSAL PRECAUTIONS(2013-II)

ORTHOPAEDICS
ORTHOPAEDIC TRAUMA;INTRODUCTION
CLASSIFICATION OF FRACTURES (2017-I*)

SPRAIN(2017-I)

TREATMENT OF FRACTURES: GENERAL PRINCIPLES

OPEN FRACTURE(2017-II*)

CLASSIFICATION OF OPEN FRACTURE(2019-I*)

SKELETAL TRACTION -ADVANTAGE & DISADVANTAGE(2022-II)

SPLINTS, TRACTIONS & PROSTHETICS

TRACTION(2012-I)

FUNCTIONAL CAST BRACING(2021-II)

COMPLICATIONS OF FRACTURE
FAT EMBOLISM(2018-I,2012-II,2007-I)

NON UNION AND ITS Mx(2009-II*,2019-II)

AVASCULAR NEUROMA(2007-I)

DESCRIBE FRACTURE NON UNION & DESCRIBE CLASSIFICATION& AETIOLOGY

OF FRACTURE NON UNION(2021-II*)

COMPLICATIONS OF FRACTURE & ITS MX (2018-I*,2016-I,2005-I)

ETIOLOGY, PATHOLOGY, CLINICAL FEATURES, INVESTIGATION & MX OF

FRACTURE OF LOWER END OF RADIUS. COMPLICATION OF FRACTURE AND
MX(2014-I*)

CLASSIFICATION OF NERVE INJURIES (2015-II,2014-I)

34 | P a g e
COMPARTMENT SYNDROME(2012-I,2010-II*,2021-II)

STAGES OF FRACTURE HEALING(2019-I)

PERIPHERAL NERVE INJURIES

WRIST DROP(2018-I,2022-I)

RADIAL NERVE PALSY / INJURY DUE TO FRACTURE OF HUMERUS (2022-

II*,2016-I,2016-II,2006-II,2008-I)

FOOT DROP(2018-II,2021-I)

TINEL’S SIGN(2016-II)

ERB’S PALSY(2010-II)

SATURDAY NIGHT PALSY(2021-I)

ULNAR CLAW HAND(2008-II)

INJURIES AROUND THE SHOULDER, FRACTURE HUMERUS

RECURRENT DISLOCATION OF SHOULDER(2017-I*)

CLASSIFICATION, PRINCIPAL & COMPLICATION OF SHOULDER

DISLOCATION(2017-II*)

ANTERIOR DISLOCATION OF SHOULDER(2015-II*)

SHOULDER DISLOCATION(2011-II*)

CLINICAL FEATURES OF ACUTE SHOULDER DISLOCATION & Mx IN

ADULTS(2010-II*)

COMPLICATION OF FRACTURE SCAPHOID & Mx (2019-II*)

INJURIES AROUND ELBOW

CLASSIFICATION, MX & COMPLICATIONS OF SUPRACONDYLAR FACTURE(2018-
I*,2017-II*)

DEFINE FRACTURE. SUPRACONDYLAR FRACTURE OF HUMERUS – CLINICAL

FEATURES & MX (2014-I*,2007-I,2019-I*,2022-I*)
35 | P a g e
SUPRACONDYLAR FRACTURE OF HUMERUS IN CHILDREN (2016-I,2014-I,2012-
II*,2010-II*,2009-II*,2008-I*,2020-I)

OSSIFICATION CENTRE AROUND THE ELBOW(2018-II)

PULLED ELBOW(2017-II)

FRACTURE OF HEAD OF RADIUS / LOWER END OF RADIUS(2016-II,2016-I)

ETIOLOGY, PATHOLOGY, CLINICAL FEATURES, INVESTIGATION & MX OF

FRACTURE OF LOWER END OF RADIUS. COMPLICATION OF FRACTURE AND
MX(2014-I*)

VOLKMANN’S ISCHAEMIC CONTRACTURE (VIC)(2011-II,2009-I*,2006-II,2021-II)

CARRYING ANGLE OF ELBOW(2011-II)

GALLAZI FRACTURE DISLOCATION(2006-I)

GOLFER ELBOW(2021-I)

INJURIES OF THE FOREARM & WRIST

COLLES FRACTURE(2017-I*,2011-II*,2006-I,2008-I,2022-I*,2019-II*)

MONTEGIA FRACTURE DISLOCATION(2006-II,2008-II)

FRACTURE COLLACRANE(2021-II,2022-II)

FRACTURE BARTON(2007-II)

INJURIES AROUND HIP

TROCHANTERIC FRACTURES, CLASSIFICATION, COMPLICATIONS & IT’S MX IN
65 YEARS FEMALE(2018-I*)

CLASSIFICATION OF FRACTURE OF NECK OF FEMUR(2016-I*)

CLASSIFICATION & MX OF FRACTURE NECK FEMUR IN DIFF. AGE GROUP(2016-

II*)

CLINICAL FEATURES, DIAGNOSIS & MX OF FRACTURE NECK FEMUR / +

CLASSIFICATION (2013-II*,2013-I*,2021-I*)

36 | P a g e
FRACTURE NECK FEMUR (2012-I*,2006-II,2009-I*)

COMPLICATION OF INTRACAPSULAR NECK FEMUR(2007-II)

INJURIES TO LEG ,ANKLE & FOOT

MARCH FRACTURE(2018-II*)

COMPPUND FRACTURE TIBIA(2006-I*)

COMPLICATIONS OF FRACTURE SHAFT TIBIA & Mx(2019-II*)

SUBTALAR ARTHRITIS(2020-II)

INFECTIONS OF BONES & JOINTS

CHRONIC OSTEOMYELITIS & MX / ETIOPATH, CLINICAL FEATURES & MX(2018-
I,2015-II,2012-I,2009-I,2022-I*,2014-I*,2022-II*)

MX OF OSTEOMYELITIS(2016-I*)

ACUTE OSTEOMYELITIS (2016-II*,2008-I*,2019-II)

RADIOLOGICAL FINDINGS OF CHRONIC OSTEOMYELITIS(2013-II)

CAUSES, CLINICAL FEATURES, INVESTIGATIONS, CLASSIFICATION, MX &

COMPLICATIONS OF INFECTED NON-UNION FRACTURE OF SHAFT OF
TIBIA(2014-I*)

SEPTIC ARTHRITIS(2013-I,2007-I*,2009-II)

BRODIE’S ABSCESS(2012-II)

UNICAMAREL BONE CYST(2022-I)

PSOAS ABSCESS(2007-II)

TUBERCULOSIS OF BONES & JOINTS

PARAPLEGIA FOLLOWING COLD ABSCESS(2014-I)

ETIOLOGY, PATHOLOGY, CLINICAL FEATURES, D/D & MX OF TB SPINE(2013-

II*,2008-II,2021-II*,2019-I)

37 | P a g e
ETIOPATH, CLINICAL FEATURES, D/D & MX OF TB HIP(2013-I*,2006-II*)

TB OF HIP JOINT(2012-I*)

TB OF KNEE JOINT(2012-II*,2009-II)

POTT PARAPLEGIA(2009-I,2007-I,2007-II*)

SPINA VENTOSA(2006-I)

CONGENITAL TALIPES EQUINO VARUS (CTEV)

MX OF CTEV (2016-I*,2008-II*,2O22-II*)

CTEV(2014-I*,2013-I*,2006-II*,2007-II*,2014-I,2015-II,2012-I,2010-II)

CLINICAL FEATURES & Mx OF CTEV(2021-I*,2021-II*)

CONGENITAL DISLOCATION OF THE HIP & OTHER

MALFORMATIONS
CONGENITAL DISLOCATION OF HIP / CONGENITAL DYSPLASIA OF HIP(2020-
I,2018-I,2016-I,2007-I*)

ETIOPATH, CLINICAL FEATURES & MX OF CDH(2013-II*)

FLAT FOOT(2006-I)

POSTERIOR HIP DISLOCATION(2022-II)

BONE TUMOURS
CLINICAL & RADIOLOGICAL FEATURES OF GIANT CELL TUMOUR(2018-II,2009-
II,2019-I)

MX OF GIANT CELL TUMOUR(2016-I)

CLINICAL FEATURES & MX OF OSTEOCLASTOMA (2015-II,2014-I*)

OSTEOCLASTOMA(2013-I)

GIANT CELL TUMOUR(2012-I*,2007-I*,2008-I,2019-II,2020-I,2022-I,2022-II)

OSTEOSARCOMA(2016-I*,2012-II*,2011-II*)

38 | P a g e
DIAGNOSIS, PRESENTATION & MX OF OSTEOSARCOMA(2014-II*)

EWING’S SARCOMA(2016-II,2014-I,2006-II*,2009-I)

OSTEOID OSTEOMA (2014-II)

ANEURYSMAL BONE CYST(2013-II)

OSTEOCHONDROMA(2007-II*,2021-I)

CHONDRO SARCOMA(2010-II)

PROLAPSED INTERVERTEBRAL DISC

AT L4-L5(2014-I)

SPINAL INJURIES
MX OF FRACTURE SPINE AT D12 / L1 LEVEL WITH COMPLETE
PARAPLEGIA(2015-II*,2014-II*)

EARLY ONSET POTT’S PARAPLEGIA(2007-II)

ARTHRITIS & RELATED DISORDERS

CLINICAL FEATURES OF RA(2017-I)

RADIOLOGICAL FINDINGS IN RA(2017-II)

RHEUMATOID ARTHRITIS AND ITS Mx(2009-I*)

PHARMACOLOGY OF GOUT(2014-II)

GOUT(2008-II)

ETIOLOGY, CLINICAL FEATURES & MX OF GOUT(2013-I)

NEWER DRUGS IN RHEUMATOID ARTHRITIS(2014-II)

DEGENERATIVE DISORDER
OSTEOARTHRITIS OF KNEE JOINT(2016-I,2006-I*,2010-II,2008-II*)

DEGENERATIVE OSTEOARTHRITIS(2013-II)

39 | P a g e
 AFFECTIONS OF SOFT TISSUES
CARPAL TUNNEL SYNDROME – CAUSES & RX(2017-II,2014-II,2012-II,2011-II)

CARPAL TUNNEL SYNDROME(2015-I*,2019-II)

PLANTER FASCITIS(2016-II)

DE QUERVAIN’S DISEASE(2016-I)

TRIGGER FINGER(2011-II)

METABOLIC BONE DISEASE

RADIOLOGICAL & CLINICAL FEATURES OF RICKETS & MX(2018-I)

RADIOLOGICAL FINDINGS OF RICKETS(2014-I)

RICKETS(2013-II)

RENAL RICKETS(2018-II*)

ETIOPATH & MX OF NUTRITIONAL RICKETS WITH BILATERAL GENU

VARUM(2014-II*)

OSTEOPOROSIS(2009-II)

RADIOLOGICAL DIAGNOSIS & MEDICAL MX OF SENILE POSTMENOPAUSAL

OSTEOPOROSIS(2014-I)

MEDICAL Mx OF SENILE OSTEOPOROSIS (2008-II*)

RICKETS,OSTEOMALACIA ,OSTEOPOROSIS(2008-I*)

OSTEOMALACIA (2012-II)

MISC
ARDS(2018-II*)

PALMAR GANGLION (2017-I)

HUGH OWEN THOMAS CONTRIBUTION IN ORTHO(2017-I)

SIR ROBERT JONES CONTRIBUTION TO ORTHO(2017-II)

40 | P a g e
CLASSIFICATION & PRINCIPLE MX OF LONG BONE FRACTURE(2016-II*)

SHORT MUSCLES OF HAND(ANATOMY(2013-I)

OSGOOD SCHALTER DISEASE(2022-I)

41 | P a g e